Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
5 pending office actions • 4 art units • 5 examiners • 0 of 5 (0%) have an AI response strategy ready
The Terasaki Institute For Biomedical Innovation is managing 5 pending office actions within the Biotechnology & Pharmaceuticals technology area. These actions are spread across 5 distinct examiners and 4 distinct art units. This level of dispersion indicates that the institute is pursuing a variety of distinct biological or pharmaceutical innovations that require review from multiple specialized groups.
The busiest examiner, WISTNER, SARAH CLINKSCALES, is currently handling 1 pending office action. Because each of the distinct examiners is managing only 1 action, the portfolio is not concentrated under any single individual. This requires the institute to manage the separate examiner relationships across 4 different art units to advance its pending applications.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (20%) |
| Double-patenting + other | 1 (20%) |
| Multi-statute (no §101) | 3 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WISTNER, SARAH CLINKSCALES | 1 | 25.0% | +81.0% |
| GHALI, ISIS A D | 1 | 27.9% | +41.6% |
| MERCHLINSKY, JOSEPH CULLEN | 1 | 5.9% | -6.3% |
| TRAN, LIEN THUY | 1 | 28.6% | +26.5% |
| WESTON, ALYSSA G | 1 | 59.8% | +50.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18281000 | SYSTEMS AND METHODS OF PRODUCING FAT TISSUE FOR CELL-BASED MEAT PRODUCTS | TRAN, LIEN THUY | 127d overdue |
| 18868963 | SYSTEMS AND METHODS FOR SHEAR-THINNING HEMOSTATS, INCLUDING THERMORESPONSIVE HEMOSTATS | WISTNER, SARAH CLINKSCALES | — |
| 18286309 | ANTIMICROBIAL ARTICLES, METHODS OF MAKING AND USING SAME | GHALI, ISIS A D | — |
| 18280994 | CONSTRUCTS COMPRISING FIBRIN OR OTHER BLOOD PRODUCTS FOR MEAT CULTIVATION AND OTHER APPLICATIONS | MERCHLINSKY, JOSEPH CULLEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18281000 | SYSTEMS AND METHODS OF PRODUCING FAT TISSUE FOR CELL-BASED MEAT PRODUCTS | TRAN, LIEN THUY | 127d overdue |
| 18868963 | SYSTEMS AND METHODS FOR SHEAR-THINNING HEMOSTATS, INCLUDING THERMORESPONSIVE HEMOSTATS | WISTNER, SARAH CLINKSCALES | — |
| 18286309 | ANTIMICROBIAL ARTICLES, METHODS OF MAKING AND USING SAME | GHALI, ISIS A D | — |
| 18281032 | PRODUCTION OF HEME FOR CELL-BASED MEAT PRODUCTS | WESTON, ALYSSA G | — |
| Art Unit | Apps |
|---|---|
| 1611 | 1 |
| 1791 | 1 |
| 1793 | 1 |
| 1633 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18868963 | SYSTEMS AND METHODS FOR SHEAR-THINNING HEMOSTATS, INCLUDING THERMORESPONSIVE HEMOSTATS | WISTNER, SARAH CLINKSCALES | — | §102§103§112 | Non-Final OA | — | Pending | Nov 25, 2024 |
| 18286309 | ANTIMICROBIAL ARTICLES, METHODS OF MAKING AND USING SAME | GHALI, ISIS A D | 1611 | §103§112 | Final Rejection | — | Pending | Oct 10, 2023 |
| 18280994 | CONSTRUCTS COMPRISING FIBRIN OR OTHER BLOOD PRODUCTS FOR MEAT CULTIVATION AND OTHER APPLICATIONS | MERCHLINSKY, JOSEPH CULLEN | 1791 | §103 | Final Rejection | — | Pending | Sep 08, 2023 |
| 18281000 | SYSTEMS AND METHODS OF PRODUCING FAT TISSUE FOR CELL-BASED MEAT PRODUCTS | TRAN, LIEN THUY | 1793 | §102§112 | Non-Final OA | 127d overdue | Pending | Sep 08, 2023 |
| 18281032 | PRODUCTION OF HEME FOR CELL-BASED MEAT PRODUCTS | WESTON, ALYSSA G | 1633 | §103§112DP | Non-Final OA | — | Pending | Sep 08, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial